Oral Thin Films
AssigneeUniversity of Strathclyde
InventorAlexander Balfour Mullen
Life of this patent
Estimating the term…
Abstract
An orally dissolvable film includes at least one layer comprising a first pharmaceutically active ingredient; a resinate comprising an ion exchange resin and a second pharmaceutically active ingredient; and a matrix and/or binder. The provision of a first pharmaceutically active ingredient, e.g., dispersed or dissolved in the film, and of a resinate comprising an ion exchange resin and a second pharmaceutically active ingredient, may allow immediate release of the first active ingredient, and controlled, sustained and/el or delayed release of the second active ingredient.
Claims26
An orally dissolvable film including at least one layer comprising:
- a first pharmaceutically active ingredient;
- a resinate comprising an ion exchange resin and a second pharmaceutically active ingredient;
- and
- a matrix and/or binder.
An orally dissolvable film including at least one layer comprising:
- a first resinate comprising a first ion exchange resin and a first pharmaceutically active ingredient;
- a second resinate comprising a second ion exchange resin and a second pharmaceutically active ingredient;
- and
- a matrix and/or binder.
A method of delivering one or more pharmaceutically active ingredients to a subject, the method comprising administering orally an orally dissolvable film including at least one layer comprising:
- a first pharmaceutically active ingredient;
- a resinate comprising an ion exchange resin and a second pharmaceutically active ingredient;
- and
- a matrix and/or binder.
Dependencies are inferred from the claim text.